Showing results (451-460 of 4,672) with videos related to
Sort By:
Pageof 468
Journal of Neural Transmission (Vienna, Austria : 1996)|August 26, 2003
Synaptic vesicle transport and synaptic membrane transporter sites in excitatory amino acid nerve terminals in Alzheimer diseaseR I Westphalen, H L Scott, P R DoddJournal of Neural Transmission (Vienna, Austria : 1996)|August 26, 2003
Polymorphism in the peroxisome proliferator-activated receptor alpha gene influences the risk for Alzheimer's diseaseS Brune, H Kölsch, U Ptok, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|August 26, 2003
Inhibition of energy metabolism down-regulates the Alzheimer related presenilin 2 geneR Ghidoni, L Gasparini, A Alberici, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|January 24, 2003
Polymorphisms of the alpha-synuclein promoter: expression analyses and association studies in Parkinson's diseaseC Holzmann, R Krüger, A M M Vieira Saecker, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|January 24, 2003
The role of diet in cognitive declineV Solfrizzi, F Panza, A CapursoJournal of Neural Transmission (Vienna, Austria : 1996)|October 10, 2002
New perspectives on neurochemical effects of amantadine in the brain of parkinsonian patients: a PET - [(11)C]raclopride studyR M Moresco, M A Volonte, C Messa, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|December 18, 2002
Moderate hyperhomocysteinaemia and immune activation in Parkinson's diseaseB Widner, F Leblhuber, B Frick, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|March 23, 2001
Evidence of melatonin involvement in pindolol-induced suppression of REM sleepJ M Monti, H Jantos, D MontiJournal of Neural Transmission (Vienna, Austria : 1996)|March 23, 2001
Switching from pergolide to pramipexole in patients with Parkinson's diseaseP A Hanna, L Ratkos, W G Ondo, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|March 23, 2001
A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapyS Pal, K F Bhattacharya, C Agapito, et al.Pageof 468